Porphyrias

Journal of Clinical Gastroenterology

Volumn 27, Issue 3, 1998, Pages 192-198

  Scarlett, Yolanda V ^a   Brenner, David A ^a  

^a UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

Author keywords

Enzyme; Heme biosynthesis; Porphyria

Indexed keywords

CLINICAL FEATURE; ENZYME DEFECT; GENETIC DISORDER; HEME SYNTHESIS; HUMAN; METABOLIC DISORDER; PORPHYRIA; PRIORITY JOURNAL; REVIEW;

DIAGNOSIS, DIFFERENTIAL; ENZYMES; GENETIC PREDISPOSITION TO DISEASE; HEME; HUMANS; PORPHYRIAS;

EID: 0031732084     PISSN: 01920790     EISSN: None     Source Type: Journal    
DOI: 10.1097/00004836-199810000-00003     Document Type: Review

References (16)

1. Grandchamp B. Acute intermittent porphyria. Semin Liver Dis 1998;18:17-24.
2. Tishler PV, Woodard B, O'Connor J, et al. High prevalence of intermittent acute porphyria in a psychiatric patient population. Am J Psychiatry 1985;142:1430-6.
3. Chen CH, Astrin KH, Lee G, et al. Acute intermittent porphyria: identification and expression of exonic mutations in the hydroxymethylbilane synthase gene. An initiation codon missense mutation in the housekeeping transcript causes "variant acute intermittent porphyria" with normal expression of the erythroid-specific enzyme. J Clin Invest 1994;94:1927-37.
4. Mustajoki P, Nordmann Y. Early administration of heme arginate for acute porphyric attacks. Arch intern Med 1993;153:2004-8.
5. Harber LC, Bickers DR. In: Photosensitivity diseases: principles of diagnosis and treatment. Philadelphia: WB Saunders, 1981: 189-223.
6. Elder GH. Porphyria cutanea tarda. Semin Liver Dis 1998; 18: 67-75.
7. Navas S, Bosch O, Castillo I, et al. Porphyria cutanea tarda and hepatitis C and B virus infection: a restrospective study. Hepatology 1995;231:279-84.
8. DeCastro M, Sanchez J, Herrera JF, et al. Hepatitic C virus antibodies and liver disease in patients with porphyria cutanea tarda. Hepatology 1993;17:551-7.
9. Fargion S, Piperno A, Cappellini MD, et al. Hepatitis C virus and porphyria cutanea tarda: evidence of a strong association. Hepatology 1993;16:1322-6.
10. Herrero C, Vicente A, Bruguera M, et al. Is hepatitis C virus infection a trigger of porphyria cutanea tarda? Lancet 1993;341:788-9.
11. Bonkovsky HL, Poh-Fitzpatrick M, Pimstone N, et al. Porphyria cutanea tarda, hepatitis C and HFE gene mutations in North America. Hepatology 1998;27:1661-9.
12. Elder GH, Roberts AG. Uroporphyrinogen decarboxylase. J Bioenerg Biomembr 1997;27:207-14.
13. Daniell WE, Stockbridge HL, Labbe RF, et al. Environmental chemical exposures and disturbances of heme synthesis. Environmental Health Perspectives 1997;105(suppl 1):37-53.
14. Logan GM, Weimer MK, Ellefson M, et al. Bile porphyrin analysis in the evaluation of variegate porphyria. N Engl J Med 1991; 324:1408-11.
15. Bloomer JR, Straka JG, Rank JM. The porphyrias. In Schiff L, Schiff ER, eds. Diseases of the liver. Philadelphia: JB Lippincott, 1993:1438-64.
16. Herbert A, Corbin D, Williams A, et al. Erythropoietic protoporphyria: unusual skin and neurological problems after liver transplantation. Gastroenterology 1991;100:1753-7.